Literature DB >> 7630628

Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.

S A Moodie1, M Paris, E Villafranca, P Kirshmeier, B M Willumsen, A Wolfman.   

Abstract

Ras proteins function through the formation of specific complexes with Raf-1, B-raf, PI-3 kinase and RalGDS. These interactions all require Ras-GTP with an intact effector binding domain (Switch I region). We have examined the requirements of the Switch II region (amino acids 60-72) for the production of stable interactions between Ras and its downstream effectors. A point mutation at position 65 or 64 combined with additional mutations at either position 65 or 71 rendered nucleotide-free Ras protein unable to stably interact with Ras specific guanine nucleotide exchange factors. Ha-Ras containing point mutations at positions 65 and 71 possessed a twofold higher affinity for B-raf and consequently MEK1. The point mutation at 64, in combination with additional point mutations at either position 65 or 71, resulted in a protein which failed to interact with either PI-3 kinase or neurofibromin, though these Ras mutants effectively bound both Raf-1 and B-raf. An activated form of Ras, Q61L-Ras, associated with all effector proteins independent of the bound guanine nucleotide. Q61L-Ras-GDP was almost as effective as wild type Ras-GMPPNP in the in vitro activation of MEK1 and MAP kinase. Competitive studies with the catalytic domain if neurofibromin, NF1-GRD, demonstrated that its interaction with Ras-GMPPNP is mutually exclusive with both Raf-1 and B-raf. These data suggest that rasGAP and neurofibromin are unable to downregulate Ras-GTP complexed to Raf-1 or B-raf.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630628

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Cloning and characterization of rac-like cDNAs from Arabidopsis thaliana.

Authors:  P Winge; T Brembu; A M Bones
Journal:  Plant Mol Biol       Date:  1997-11       Impact factor: 4.076

2.  Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons.

Authors:  K A Park; J C Fehrenbacher; E L Thompson; D B Duarte; C M Hingtgen; M R Vasko
Journal:  Neuroscience       Date:  2010-09-24       Impact factor: 3.590

3.  Transformation efficiency of RasQ61 mutants linked to structural features of the switch regions in the presence of Raf.

Authors:  Greg Buhrman; Glenna Wink; Carla Mattos
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

4.  Conformationally variable Rab protein surface regions mapped by limited proteolysis and homology modelling.

Authors:  L Nikolova; K Soman; J C Nichols; D S Daniel; B F Dickey; S Hoffenberg
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

5.  Allosteric modulation of Ras positions Q61 for a direct role in catalysis.

Authors:  Greg Buhrman; Genevieve Holzapfel; Susan Fetics; Carla Mattos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

6.  The novel duplication HRAS c.186_206dup p.(Glu62_Arg68dup): clinical and functional aspects.

Authors:  Karen W Gripp; Laura Baker; Katherine M Robbins; Deborah L Stabley; Gary A Bellus; Verena Kolbe; Theresa Nauth; Georg Rosenberger
Journal:  Eur J Hum Genet       Date:  2020-06-04       Impact factor: 4.246

7.  Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation.

Authors:  Severa Bunda; Pardeep Heir; Tharan Srikumar; Jonathan D Cook; Kelly Burrell; Yoshihito Kano; Jeffrey E Lee; Gelareh Zadeh; Brian Raught; Michael Ohh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

8.  Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways.

Authors:  Aparna Kaul; Jean H Overmeyer; William A Maltese
Journal:  Cell Signal       Date:  2006-11-28       Impact factor: 4.315

Review 9.  Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.

Authors:  Jonathan M L Ostrem; Kevan M Shokat
Journal:  Nat Rev Drug Discov       Date:  2016-07-29       Impact factor: 84.694

10.  Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.

Authors:  E M Weissinger; G Eissner; C Grammer; S Fackler; B Haefner; L S Yoon; K S Lu; A Bazarov; J M Sedivy; H Mischak; W Kolch
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.